BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11156375)

  • 1. Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer.
    Hosch S; Kraus J; Scheunemann P; Izbicki JR; Schneider C; Schumacher U; Witter K; Speicher MR; Pantel K
    Cancer Res; 2000 Dec; 60(24):6836-40. PubMed ID: 11156375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer.
    Izbicki JR; Hosch SB; Pichlmeier U; Rehders A; Busch C; Niendorf A; Passlick B; Broelsch CE; Pantel K
    N Engl J Med; 1997 Oct; 337(17):1188-94. PubMed ID: 9337377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
    Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
    J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of detecting mucin 1 mRNA in diagnosing occult lymph node micrometastasis in esophageal cancer patients.
    Liu XY; Chen G; Wang Z; Liu FY
    Ai Zheng; 2007 Feb; 26(2):194-9. PubMed ID: 17298752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of nodal micrometastases in patients with cancer of the gastro-oesophageal junction.
    Heeren PA; Kelder W; Blondeel I; van Westreenen HL; Hollema H; Plukker JT
    Eur J Surg Oncol; 2005 Apr; 31(3):270-6. PubMed ID: 15780562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
    Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
    J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining.
    Gockel I; Domeyer M; Sgourakis GG; Schimanski CC; Moehler M; Kirkpatrick CJ; Lang H; Junginger T; Hansen T
    J Surg Oncol; 2009 Sep; 100(3):191-8. PubMed ID: 19548259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
    Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
    Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma.
    Messerini L; Cianchi F; Cortesini C; Comin CE
    Hum Pathol; 2006 Oct; 37(10):1259-67. PubMed ID: 16949928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central mesenteric lymph node BER-Ep4+ cells in colorectal cancer: challenge to sentinel node concept?
    Schurr PG; Behnke S; Kaifi JT; Bogoevski D; Link B; Mann O; Strate T; Pantel K; Izbicki JR; Yekebas E
    Dig Surg; 2007; 24(1):19-27. PubMed ID: 17369677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
    Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
    Reed W; Bøhler PJ; Sandstad B; Nesland JM
    Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of the size of cancer nests in metastatic lymph nodes in human esophageal cancers.
    Komori T; Doki Y; Kabuto T; Ishikawa O; Hiratsuka M; Sasaki Y; Ohigashi H; Murata K; Yamada T; Miyashiro I; Mano M; Ishiguro S; Imaoka S
    J Surg Oncol; 2003 Jan; 82(1):19-27. PubMed ID: 12501165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
    Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
    Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of disseminated lung cancer cells in lymph nodes by monoclonal antibodies: impact on staging and prognosis.
    Passlick B
    Ann Ital Chir; 1999; 70(6):839-40. PubMed ID: 10804658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis.
    Soumaoro LT; Uetake H; Takagi Y; Iida S; Higuchi T; Yasuno M; Enomoto M; Sugihara K
    Dis Colon Rectum; 2006 Mar; 49(3):392-8. PubMed ID: 16474989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multi-antibody combined determination of lymph node micrometastasis in patients with gastric cancer].
    Wang GY; Wang SJ; Li Y; Wang LL; Wang XL; Song ZC; Fan LQ
    Ai Zheng; 2004 May; 23(5):559-63. PubMed ID: 15142454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node-negative esophageal cancer patients.
    Godfrey TE; Raja S; Finkelstein SD; Gooding WE; Kelly LA; Luketich JD
    Clin Cancer Res; 2001 Dec; 7(12):4041-8. PubMed ID: 11751499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma.
    Koenig AM; Prenzel KL; Bogoevski D; Yekebas EF; Bubenheim M; Faithova L; Vashist YK; Gawad KA; Baldus SE; Pantel K; Schneider PM; Hölscher AH; Izbicki JR
    Ann Surg Oncol; 2009 Feb; 16(2):454-62. PubMed ID: 19015923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.